Opioids workshops announced

Opioid Workshops

An ongoing problem with prescrip­tion opioids includes the state of Washington. This prompted two recent actions. The first happened in October 2016 when Governor Inslee signed Execu­tive Order 16 – 09. In that order, he charac­ter­ized opioid use disorder as a devas­tating and life-threat­ening medical condi­tion.” He also called for actions to reduce opioid misuse and abuse. 

The second action happened during the 2017 legisla­tive session. The legis­la­ture consid­ered several bills to address the issue of opioid use disorder. Ultimately, the legis­la­ture passed Engrossed Substi­tute House Bill (ESHB) 1427 and the governor signed it into law. 

As part of the imple­men­ta­tion of 1427, there will be a series of seven workshops held around the state to imple­ment ESHB 1427. The first of these is sched­uled for: 

September 20th, 9 am: 

Capital Event Center 

6005 Tyee Dr SW, Tumwater, WA 98512 

Wednesday, September 20 in the Chehalis AB Room 


The objec­tives for the workshops are in two parts: 

For the boards and commis­sions, repre­sen­ta­tives from the five boards and commis­sions (see sidebar) will form a workgroup to create prescribing rules, much as they did in 2011 for the chronic non-cancer pain rules. This workgroup’s key aims are to: 

  • Generate a boiler­plate set of prescribing rules; 
  • Create uniform recom­men­da­tions on revising existing pain manage­ment rules; 
  • Forward the boiler­plate rules to each board and commis­sion to adopt under their own authority; and 
  • Coordi­nate educa­tion and outreach campaigns. 

For the PMP reporting and metrics: 

  • Estab­lish an overdose notifi­ca­tion message for providers; 
  • Deter­mine the infor­ma­tion and metrics to be provided to facil­i­ties, groups, and the Washington State Hospital Association; 
  • Create formats and metrics for prescriber feedback reports; and 
  • Develop commu­ni­ca­tion and technical assistance. 

The deadline for the boards and commis­sions to adopt their rules is January 1, 2019. The PMP plans to complete its work during this same time. 

The seven workshop meetings are open public meetings. The public is welcome to attend and will have an oppor­tu­nity to give comments. Another notice will come out soon with the other dates and locations.

Effects of ESHB 1427 #

  • Expanding access to PMP data to govern­ment, including personnel within the Depart­ment of Health (depart­ment), the Health Care Authority, and local health offices.
  • Sharing PMP data with health care facil­i­ties and groups of at least five prescribers.
  • Allowing hospi­tals to receive PMP data through their contin­uous quality improve­ment programs.
  • Directing the depart­ment to develop an overdose-event notifi­ca­tion letter to be sent to prescribers when these events occur.
  • Creating a feedback reporting mecha­nism for providers of their prescribing practices in compar­ison to others in similar practice specialties.
  • And finally, it directs the following boards and commis­sions to create prescribing rules for using opioids for acute, subacute and periop­er­a­tive pain (which may include making changes to the existing chronic non-cancer pain rules):
  • Board of Osteo­pathic Medicine and Surgery;
  • Dental Quality Assur­ance Commission;
  • Medical Quality Assur­ance Commission;
  • Nursing Care Quality Assur­ance Commis­sion; and
  • Podiatric Medical Board.

The boards and commis­sions must consider the revised Agency Medical Direc­tors Group and Centers for Disease Control guide­lines; and consult with their profes­sions’ associ­a­tions, the Depart­ment of Health, and the Univer­sity of Washington.